Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Hypofractionated radiotherapy for prostate cancer.

Hegemann NS, Guckenberger M, Belka C, Ganswindt U, Manapov F, Li M.

Radiat Oncol. 2014 Dec 6;9(1):275. [Epub ahead of print]

PMID:
25480014
[PubMed - as supplied by publisher]
Free PMC Article
2.

Intensity-modulated radiotherapy for lung cancer: current status and future developments.

Chan C, Lang S, Rowbottom C, Guckenberger M, Faivre-Finn C; IASLC Advanced Radiation Technology Committee.

J Thorac Oncol. 2014 Nov;9(11):1598-608. doi: 10.1097/JTO.0000000000000346.

PMID:
25436795
[PubMed - in process]
3.

Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.

Guckenberger M, Mantel F, Gerszten PC, Flickinger JC, Sahgal A, Létourneau D, Grills IS, Jawad M, Fahim DK, Shin JH, Winey B, Sheehan J, Kersh R.

Radiat Oncol. 2014 Oct 16;9(1):226. [Epub ahead of print]

PMID:
25319530
[PubMed - as supplied by publisher]
Free PMC Article
4.

Stereotactic body radiotherapy for centrally located stage I NSCLC : A multicenter analysis.

Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M.

Strahlenther Onkol. 2014 Aug 27. [Epub ahead of print]

PMID:
25159135
[PubMed - as supplied by publisher]
5.

Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.

Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M.

Strahlenther Onkol. 2014 Oct;190(10):872-81. doi: 10.1007/s00066-014-0714-1. Epub 2014 Aug 5.

PMID:
25091267
[PubMed - indexed for MEDLINE]
6.

Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases.

Mantel F, Glatz S, Toussaint A, Flentje M, Guckenberger M.

Strahlenther Onkol. 2014 Nov;190(12):1141-8. doi: 10.1007/s00066-014-0706-1. Epub 2014 Jun 27.

PMID:
24969225
[PubMed - indexed for MEDLINE]
7.

Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.

Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M, Grosu AL, Guckenberger M.

Strahlenther Onkol. 2014 Jun;190(6):521-32. doi: 10.1007/s00066-014-0648-7. Epub 2014 Apr 9. Review.

PMID:
24715242
[PubMed - indexed for MEDLINE]
8.

Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.

Müller K, Schlamann A, Guckenberger M, Warmuth-Metz M, Glück A, Pietschmann S, Wawer A, Kortmann RD, Kramm C, von Bueren AO.

Strahlenther Onkol. 2014 Apr;190(4):377-81. doi: 10.1007/s00066-013-0513-0. Epub 2014 Feb 19.

PMID:
24638239
[PubMed - indexed for MEDLINE]
9.

Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.

Kestin L, Grills I, Guckenberger M, Belderbos J, Hope AJ, Werner-Wasik M, Sonke JJ, Bissonnette JP, Xiao Y, Yan D; Elekta Lung Research Group.

Radiother Oncol. 2014 Mar;110(3):499-504. doi: 10.1016/j.radonc.2014.02.002. Epub 2014 Mar 11.

PMID:
24630539
[PubMed - in process]
10.

Suitability of markerless EPID tracking for tumor position verification in gated radiotherapy.

Serpa M, Baier K, Cremers F, Guckenberger M, Meyer J.

Med Phys. 2014 Mar;41(3):031702. doi: 10.1118/1.4863597.

PMID:
24593706
[PubMed - indexed for MEDLINE]
11.

Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine.

Guckenberger M.

J Thorac Oncol. 2014 Feb;9(2):e17-8. doi: 10.1097/JTO.0000000000000080. No abstract available.

PMID:
24419429
[PubMed - indexed for MEDLINE]
12.

Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7.

PMID:
24411630
[PubMed - indexed for MEDLINE]
13.

Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.

Guckenberger M, Lawrenz I, Flentje M.

Strahlenther Onkol. 2014 Jan;190(1):48-53. doi: 10.1007/s00066-013-0443-x. Epub 2013 Nov 8.

PMID:
24196279
[PubMed - indexed for MEDLINE]
14.

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.

Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M.

Radiother Oncol. 2013 Oct;109(1):13-20. doi: 10.1016/j.radonc.2013.09.005. Epub 2013 Oct 30.

PMID:
24183066
[PubMed - indexed for MEDLINE]
15.

[Stereotactic body radiotherapy for malignant nodules in the lung].

Nestle U, Guckenberger M.

Zentralbl Chir. 2013 Oct;138 Suppl 1:S25-31. doi: 10.1055/s-0033-1350866. Epub 2013 Oct 22. Review. German.

PMID:
24150852
[PubMed - indexed for MEDLINE]
16.

Studies on the role of osteopontin-1 in endometrial cancer cell lines.

Hahne JC, Meyer SR, Kranke P, Dietl J, Guckenberger M, Polat B, Hönig A.

Strahlenther Onkol. 2013 Dec;189(12):1040-8. doi: 10.1007/s00066-013-0434-y. Epub 2013 Oct 16.

PMID:
24126938
[PubMed - indexed for MEDLINE]
17.

Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.

Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O; Deutschen Gesellschaft für Radioonkologie (DEGRO).

Strahlenther Onkol. 2014 Jan;190(1):26-33. doi: 10.1007/s00066-013-0450-y. Epub 2013 Sep 21.

PMID:
24052011
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.

Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M.

Radiother Oncol. 2013 Aug;108(2):326-30. doi: 10.1016/j.radonc.2013.08.022. Epub 2013 Sep 7.

PMID:
24021342
[PubMed - indexed for MEDLINE]
19.

Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or "no-go"?

Nestle U, Faivre-Finn C, DeRuysscher D, Hurkmans C, Guckenberger M, Belderbos J, le Pechoux C.

Radiother Oncol. 2013 Oct;109(1):178-9. doi: 10.1016/j.radonc.2013.07.022. Epub 2013 Sep 7. No abstract available.

PMID:
24016673
[PubMed - indexed for MEDLINE]
20.

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.

Sassowsky M, Gut P, Hölscher T, Hildebrandt G, Müller AC, Najafi Y, Kohler G, Kranzbühler H, Guckenberger M, Zwahlen DR, Azinwi NC, Plasswilm L, Takacs I, Reuter C, Sumila M, Manser P, Ost P, Böhmer D, Pilop C, Aebersold DM, Ghadjar P.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):534-41. doi: 10.1016/j.ijrobp.2013.06.2053. Epub 2013 Aug 22.

PMID:
23972722
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk